Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials-Reference-Cited by-同舟云学术

Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials

Published:2022-03 Issue: Volume:163 Page:98-107
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Baldini Capucine,Younan Nadia,Castanon Alvarez Eduardo,Ammari Samy,Alentorn Agusti,Dumont Sarah,Frenel Jean-Sebastien,Di Stefano Anna-Luisa,Louvel Guillaume,Michot Jean-Marie,Bahleda Rastislav,Postel-Vinay Sophie,Varga Andreea,Marabelle Aurélien,Hollebecque Antoine,Bielle Franck,Hoang-Xuan Khê,Delattre Jean-Yves,Dhermain Frederic,Sanson Marc,Soria Jean-Charles,Idbaih Ahmed,Massard Christophe,Touat Mehdi

Funder

AbbVie

Bristol-Myers Squibb

Sanofi

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014;Ostrom;Neuro Oncol,2017

2. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol (Berl),2016

3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

4. Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma;Buckner;N Engl J Med,2016

5. Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH;Cairncross;J Clin Oncol Off J Am Soc Clin Oncol,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Image-Based Models for High-Grade Gliomas Might Be Accelerated;Cancers;2024-04-19

2. Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis;European Journal of Cancer;2023-09